13 Jan 2014 07:00

Â
Avacta Group plc
("Avacta" or the "Group")
Â
Investor teach-in
Â
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces it will be hosting an investor teach-in on 5 February 2014 where Alastair Smith, CEO, will provide an overview of the Avacta business. No new material information will be disclosed.
Â
Matt Johnson, who recently joined Avacta from Abcam as the Head of Research & Development of Avacta's Life Sciences division, will discuss the opportunity for Affimers, Avacta's proprietary affinity reagent platform.
Â
The event, which will include a demonstration and showcase of some of the Avacta's products, will be held from 16:30 until 19:30 in the Oriental Room at the London Capital Club, 15 Abchurch Lane, London, EC4N 7BW, followed by drinks and canapés.
Â
For more information or to register to attend, contact Walbrook PR (contact details are below).
Â
Enquiries:
Â
 |  |
Walbrook PR Limited | Tel: 020 7933 8780 or avacta@walbrookpr.com |
Anna Dunphy | Mob: 07876 741 001 |
Lianne Cawthorne | Mob: 07584 391 303 |
Â
Â
Â
Â
Â
About Avacta Group plc - www.avacta.com
Â
Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:
Â
Avacta Analytical www.avactaanalytical.com  | High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development. |
Avacta Animal Health www.avactaanimalhealth.com  | Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod. |
Avacta Life Sciences www.avactalifesciences.com  | Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development. |
Â
Avacta joined AIM in August 2006 and is based in Wetherby, England.
Â
Â
Â